Terumo Corp (4543.T) stock: key figures, P/E, revenue and dividend

Health Care · Japan · ISIN JP3546800008

Price
2,280.50 JPY
Market cap
3.36 tn JPY
P/E (2026)
24.76
P/S (2026)
2.97
Dividend yield
1.45 %
Net margin
12.01 %
Return on equity (ROE)
8.58 %
Return on assets (ROA)
5.88 %

Terumo Corp financials

Fiscal year20252026
Revenue1.04 tn JPY1.13 tn JPY
Gross profit532.78 bn JPY594.68 bn JPY
EBIT179.02 bn JPY184.74 bn JPY
Net income116.98 bn JPY135.91 bn JPY
Diluted EPS – continuing operations79.28 JPY92.11 JPY

Full history since 1991, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Terumo Corp

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular stent grafts, and others. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The Terumo Organ Technologies segment provides organ preservation devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Shibuya, Japan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 15.10.2026. Details in the risk notice.

Terumo Corp stock (4543.T): P/E, revenue, dividend | finmetric